AstraZeneca Provides An Update on the Status of its Arrangements With Merck & Co., Inc.

 View full press release

For information that puts the above announcement in historical context of the Merck arrangements, please view the presentation from the analyst seminar covering the Merck arrangements that was conducted in March 2006. Please keep in mind that some of the information in this presentation has been superceded by today's disclosures, including the anticipated accounting treatment of the termination payments and estimates for amortisation expense. Further details on the accounting treatment of these events will be provided in conjunction with AstraZeneca's Q1 2008 earnings announcement.

Analyst seminar on Merck arrangements - 14 March 2006

 Presentation with script - 711 kb